Jefferies Maintains Option Care Health(OPCH.US) With Buy Rating, Maintains Target Price $38
Jefferies analyst Brian Tanquilut maintains $Option Care Health(OPCH.US)$ with a buy rating, and maintains the target price at $38.According to TipRanks data, the analyst has a success rate of 48.9% a
Option Care Health Insiders Added US$3.22m Of Stock To Their Holdings
In the last year, multiple insiders have substantially increased their holdings of Option Care Health, Inc. (NASDAQ:OPCH) stock, indicating that insiders' optimism about the company's prospects has in
Will Weakness in Option Care Health, Inc.'s (NASDAQ:OPCH) Stock Prove Temporary Given Strong Fundamentals?
With 3.4% One-year Returns, Institutional Owners May Ignore Option Care Health, Inc.'s (NASDAQ:OPCH) 3.4% Stock Price Decline
Key Insights Given the large stake in the stock by institutions, Option Care Health's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 20 shareholder
Option Care Health Shareholders Back Leadership and Plans
Option Care Health to Participate in Upcoming Investor Conferences
BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent national provider of home and alternate site infusion services, will
Buy Rating Justified for Option Care Health Amid Revenue Growth and Strategic Adaptability
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
Option Care Health's (NASDAQ:OPCH) Solid Profits Have Weak Fundamentals
Option Care Health, Inc. (NASDAQ:OPCH) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers. NasdaqGS:OPCH
Option Care Health to Participate in the BofA Securities Health Care Conference
BANNOCKBURN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. ("Option Care Health") (NASDAQ:OPCH), the nation's largest independent national provider of home and alternate site infusion services, will
Are Investors Undervaluing Option Care Health (OPCH) Right Now?
Option Care Health, Inc. (NASDAQ:OPCH) Q1 2024 Earnings Call Transcript
Barrington Research Maintains Outperform on Option Care Health, Maintains $38 Price Target
Barrington Research analyst Michael Petusky maintains Option Care Health with a Outperform and maintains $38 price target.
Analysts Conflicted on These Healthcare Names: HealthStream (HSTM) and Option Care Health (OPCH)
Option Care Health (OPCH) Receives a Buy From Truist Financial
Q1 2024 Option Care Health Inc Earnings Call
Option Care Health Inc (OPCH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Earnings Call Summary | Option Care Health(OPCH.US) Q1 2024 Earnings Conference
The following is a summary of the Option Care Health, Inc. (OPCH) Q1 2024 Earnings Call Transcript:Financial Performance:Option Care Health reported Q1 revenue growth of over 12% and a gross profit of
Express News | Option Care Health Shares Down 2.7% After Q1 Results
No Data